BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6307665)

  • 1. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.
    Vale W; Vaughan J; Smith M; Yamamoto G; Rivier J; Rivier C
    Endocrinology; 1983 Sep; 113(3):1121-31. PubMed ID: 6307665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
    Yasuda Y; Yasuda N
    Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of adrenocorticotropin/endorphin-related peptide secretion in neonatal rat pituitary cultures.
    Sato SM; Mains RE
    Endocrinology; 1986 Aug; 119(2):793-801. PubMed ID: 2426088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin II, catecholamines and glucocorticoid on corticotropin releasing factor (CRF)-induced ACTH release in pituitary cell cultures.
    Murakami K; Hashimoto K; Ota Z
    Acta Med Okayama; 1984 Aug; 38(4):349-55. PubMed ID: 6093444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphin release: effects of acute and chronic stress.
    Young EA; Akil H
    Endocrinology; 1985 Jul; 117(1):23-30. PubMed ID: 2988916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
    Rivier C; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II, and glucocorticoids.
    Childs GV; Burke JA
    Endocrinology; 1987 Feb; 120(2):439-44. PubMed ID: 3026776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E; Negro-Vilar A
    Neuroendocrinology; 1983 Dec; 37(6):446-53. PubMed ID: 6318148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic secretagogue exposure on pro-adrenocorticotropin/endorphin production and secretion in primary cultures of rat anterior pituitary.
    Wand GS; Eipper BA
    Endocrinology; 1987 Mar; 120(3):953-61. PubMed ID: 3492370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
    Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG
    Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats.
    Murakami K; Hashimoto K; Ota Z
    Neuroendocrinology; 1984 Jul; 39(1):49-53. PubMed ID: 6087183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of several in vitro systems on the potencies of putative adrenocorticotropin secretagogues on rat anterior pituitary cells.
    Watanabe T; Orth DN
    Endocrinology; 1988 May; 122(5):2299-308. PubMed ID: 2834188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures.
    Abou-Samra AB; Catt KJ; Aguilera G
    Endocrinology; 1987 Sep; 121(3):965-71. PubMed ID: 2441983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of cultured anterior pituitary cells in detecting corticotropin releasing factor(s): the effect of biologically active peptides and neurotransmitter substances on ACTH release in pituitary cell cultures.
    Hashimoto K; Yunoki S; Hosogi H; Takahara J; Ofuji T
    Acta Med Okayama; 1979 Apr; 33(2):81-90. PubMed ID: 38634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone.
    Rivier C; Brownstein M; Spiess J; Rivier J; Vale W
    Endocrinology; 1982 Jan; 110(1):272-8. PubMed ID: 6274623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells.
    Bilezikjian LM; Vale WW
    Endocrinology; 1983 Aug; 113(2):657-62. PubMed ID: 6191964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.
    Gibbs DM; Vale W
    Endocrinology; 1982 Oct; 111(4):1418-20. PubMed ID: 6288364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.